We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

Back to rankings

67 hedge funds and large institutions have $109M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 17

0% more funds holding

Funds holding: 67 → 67 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

18% less capital invested

Capital invested by funds: $133M → $109M (-$23.8M)

88% less call options, than puts

Call options by funds: $611K | Put options by funds: $4.91M

Holders
67
Holders Change
–
Holders Change %
0%
% of All Funds
1.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
23
Reduced
17
Closed
8
Calls
$611K
Puts
$4.91M
Net Calls
-$4.3M
Net Calls Change
-$838K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$4.91M
2
Renaissance Technologies
Renaissance Technologies
New York
+$760K
3
Millennium Management
Millennium Management
New York
+$665K
4
Group One Trading
Group One Trading
Illinois
+$554K
5
NCCM
Nine Chapters Capital Management
New Jersey
+$454K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$5.57M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$782K
3
WC
Woodstock Corp
Massachusetts
-$272K
4
GCP
GSA Capital Partners
United Kingdom
-$265K
5
BIT
BlackRock Institutional Trust
California
-$242K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$392K +$183K +12,836 +70%
Morgan Stanley
27
Morgan Stanley
New York
$391K -$12.5K -877 -3%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$353K -$782K -54,858 -66%
TA
29
Teachers Advisors
New York
$338K – – –
ST
30
Spot Trading
Illinois
$333K +$362K +25,347 +2,273%
ProShare Advisors
31
ProShare Advisors
Maryland
$317K -$68.5K -4,802 -16%
State Board of Administration of Florida Retirement System
32
State Board of Administration of Florida Retirement System
Florida
$293K – – –
AQR Capital Management
33
AQR Capital Management
Connecticut
$282K – – –
Swiss National Bank
34
Swiss National Bank
Switzerland
$277K – – –
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$268K – – –
DekaBank Deutsche Girozentrale
36
DekaBank Deutsche Girozentrale
Germany
$253K +$7.13K +500 +3%
CS
37
Credit Suisse
Switzerland
$249K +$32K +2,245 +13%
HK
38
Horizon Kinetics
New York
$227K – – –
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$221K +$2.85K +200 +1%
EMG
40
Ellington Management Group
Connecticut
$198K +$224K +15,700 New
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$194K – – –
NFA
42
Nationwide Fund Advisors
Ohio
$183K +$1.91K +134 +0.9%
Goldman Sachs
43
Goldman Sachs
New York
$167K +$189K +13,276 New
VOYA Investment Management
44
VOYA Investment Management
Georgia
$161K – – –
AIG
45
American International Group
New York
$157K -$128 -9 -0.1%
Bank of America
46
Bank of America
North Carolina
$152K +$29.2K +2,046 +20%
Public Employees Retirement Association of Colorado
47
Public Employees Retirement Association of Colorado
Colorado
$151K – – –
Deutsche Bank
48
Deutsche Bank
Germany
$146K +$70.9K +4,973 +74%
BA
49
BlackRock Advisors
Delaware
$142K -$13.7K -961 -8%
Citigroup
50
Citigroup
New York
$133K -$5.38K -377 -3%
1
2
3

OSIR Hedge Fund Activity: Q3 2014 in Review

67 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2014, worth a combined $109M — down 18% from $133M a quarter earlier.

Fund positioning in OSIR was balanced in Q3 2014: 8 funds opened new positions, 8 closed out, 23 added to existing stakes and 17 trimmed.

The largest buyer was Deerfield Management, adding an estimated $4.91M. The largest seller was Consonance Capital Management, cutting an estimated $5.57M.

  • 67 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $109M of Osiris Therapeutics, Inc. Common Stock stock for Q3 2014, down 18% quarter-over-quarter.
  • 8 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2014 and 8 closed out, a net change of 0 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q3 2014 was Deerfield Management, an estimated $4.91M added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2014 was Consonance Capital Management, an estimated $5.57M sold.

Based on aggregated 13F filings for Q3 2014.